ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1625

With Chlamydia Infection the Macrophage Serves As Gate-Keeper for Dissemination and Induction of Host Immunity

Eric Gracey1 and Robert D. Inman2, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Infection and macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Infection-related Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: The obligate intracellular pathogen, Chlamydia, is the most common cause of reactive arthritis (ReA). We have demonstrated that susceptibility to experimental Chlamydia-induced ReA is determined as early as day 4 post infection implicating the innate immune response. However the cellular and molecular mechanisms during this stage have yet to be determined. Here we demonstrate the importance of the macrophage in directing both innate and adaptive immune responses to Chlamydia, and limiting dissemination of the organism.

Methods: Clodronate liposomes (CL) were used to deplete peritoneal macrophages with PBS-liposomes (PL) acting as the control. Clodronate did not affect neutrophil or lymphocyte populations. Subsequent to macrophage depletion mice were infected IP with 107 IFU Chlamydia muridarum for either 7 or 14 days. Spleens, peritoneal lavage, peritoneal membranes and blood were harvested for analysis of immune response and Chlamydia load.

Results: There was no mortality, nor signs of systemic disease associated with Chlamydia challenge in macrophage-depleted mice. Inspection of peritoneal cavity cells at day 7 demonstrated depletion of Cd11b+F4/80+ macrophages (PL; 50% of cells, CL; 5% of cells) and a significant increase in CD11b+Ly6G+ neutrophils (PL; 10% of cells, CL; 60% of cells) was seen in the mice treated with clodronate liposomes. This was coupled with a 5-fold increase in Chlamydia 16sRNA load of these cells as assessed by qPCR. 16sRNA was only detected in blood samples only in the macrophage-depleted mice, reflecting dissemination of the organism beyond the site of local challenge. At day 14 post Chlamydia infection, depletion of macrophages was associated with a significant alteration of the adaptive immune response profile, with reduced numbers of Th1 cells and activated IFNy+, CD8+ cells. This was coupled with a 20-fold increase chlamydial load compared to control mice

Conclusion: These data indicate that macrophages are crucial in defining effective host innate immune response to Chlamydia and thereby limiting dissemination of the organism. In addition, macrophages orchestrate the development of effective adaptive host response to the organism. These studies suggest that quantitative or qualitative alteration in macrophages may play a key role in the development of post-Chlamydia sequelae such as reactive arthritis.


Disclosure:

E. Gracey,
None;

R. D. Inman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/with-chlamydia-infection-the-macrophage-serves-as-gate-keeper-for-dissemination-and-induction-of-host-immunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology